Cellectis (CLLS) Payables (2013 - 2026)

Cellectis' Payables history runs 14 years deep, the most recent figure standing at $17.1 million for Q1 2026.

• On a quarterly basis, Payables fell 0.69% year-over-year to $17.1 million in Q1 2026; TTM through Mar 2026 was $17.1 million, a 0.69% decrease from a year earlier, with the FY2025 full-year figure at $17.3 million, down 7.43% from the prior year.
• Payables retreated to $17.1 million in Q1 2026 per CLLS's latest filing, from $17.3 million in the prior quarter.
• Across five years, Payables topped out at $24.2 million in Q2 2022 and bottomed at $16.1 million in Q1 2024.
• The 5-year median for Payables is $18.7 million (2024), against an average of $19.2 million.
• Across the five-year window, Payables slipped 28.1% in 2024 and grew 7.21% in 2025, its largest moves.
• Year by year, Payables stood at $21.5 million in 2022, then decreased by 11.13% to $19.1 million in 2023, then declined by 2.12% to $18.7 million in 2024, then dropped by 7.43% to $17.3 million in 2025, then slipped by 1.08% to $17.1 million in 2026.
• Per Business Quant, the three latest CLLS Payables figures stand at $17.1 million (Q1 2026), $17.3 million (Q4 2025), and $16.1 million (Q3 2025).